Search results

Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

Result type

Evidence summary

Published

9 June 2016

Recommendation ID NG106/4 Question The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart...

Result type

Research recommendation

Published

17 December 2018

NICE has developed a medtech innovation briefing (MIB) on StoneChecker for kidney stone evaluation .

Result type

Medtech innovation briefing

Published

1 February 2019

Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography.

Result type

HealthTech guidance

Published

4 October 2021

This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.

Result type

NICE guideline

Last updated

3 September 2025

Evidence-based recommendations on cabozantinib (Cabometyx) for untreated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

3 October 2018

Evidence-based recommendations on cabozantinib (Cabometyx) with nivolumab (Opdivo) for untreated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

10 April 2024

In development Reference number: GID-TA11478 Expected publication date:  11 March 2026

Result type

Technology appraisal guidance

Status

In development

Evidence-based recommendations on tivozanib (Fotivda) for treating advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

21 March 2018

Evidence-based recommendations on everolimus (Certican) for preventing organ rejection in adults having a liver transplant.

Result type

Technology appraisal guidance

Published

22 July 2015

Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

11 January 2023

This indicator has been updated and replaced by NICE indicator 322.

Published

21 August 2023

This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.

Result type

NICE guideline

Last updated

17 August 2022

In development Reference number: GID-TA11561 Expected publication date:  11 March 2026

Result type

Technology appraisal guidance

Status

In development

Evidence-based recommendations on laparoscopic nephrolithotomy and pyelolithotomy. This involves inserting a tube through small cuts in the abdomen (keyhole surgery) to remove the kidney stones.

Result type

Interventional procedures guidance

Published

28 March 2007